http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2244680-C
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18 |
filingDate | 1997-01-18^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-09-13^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4980214bbf390c8d543743df83059ef1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5baa1244c690f6a2788520e8cd209d4e |
publicationDate | 2005-09-13^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2244680-C |
titleOfInvention | Process for preparing purine derivatives |
abstract | Process for preparing the L-monovaline ester of 2-(2-amino-1,6-dihydro- 6- oxo-purin-9-yl)-methoxy-1,3-propanediol of the formula I, (See formula I) and its pharmaceutically acceptable salts. The present process provides an N ,O- bis- trityl intermediate of 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)-methoxy-1,3- propanediol which allows for monoesterification by an L-valine derivative. These products are of value as antiviral agents with improved absorption. |
priorityDate | 1996-01-26^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 125 of 125.